Medicine library

Browse medicines, page 26 of 49

Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.

Showing 1,501–1,560 of 2,899 records

Dyclonine (Dyclopro / Dyclone / Sucrets Sore Throat Wild Cherry)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Anesthetizing accessible mucous membranes (e
Dyphylline (Neothylline / Lufyllin / Dilor-400 / Dilor)
Small chemical medicineApproved in the United States (FDA)Expanded record
Echothiophate (Phospholine Iodide)
Small chemical medicineApproved in the United States (FDA)Expanded record
Eculizumab-Aagh (Epysqli)
Protein medicineApproved in the United States (FDA)Expanded record
Edaravone (Radicava / Radicava Ors)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Amyotrophic lateral sclerosis
Efbemalenograstim Alfa-Vuxw (Ryzneuta)
Protein medicineApproved in the United States (FDA)Expanded record
Efinaconazole (Jublia)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
The topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes
Elagolix Sodium, Estradiol, Norethindrone (Oriahnn (Copackaged))
Small chemical medicineApproved in the United States (FDA)Expanded record
Elexacaftor, Ivacaftor, Tezacaftor (Trikafta (Copackaged))
Small chemical medicineApproved in the United States (FDA)Expanded record
Eliglustat (Cerdelga)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
CERDELGA is indicated for the long-term treatment of adult patients with Gaucher disease type 1 (GD1) who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test [see Dosage and Administration (2.1) ] . CERDELGA is a glucosylceramide synthase inhibitor indicated for the long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test.
Elosulfase alfa (Vimizim)
Protein medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Mucopolysaccharidosis type IVA (MPS IVA
Elvitegravir (Vitekta)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
HIV-1 infection
Emapalumab-Lzsg (Gamifant)
Protein medicineApproved in the United States (FDA)Expanded record
Encorafenib (Braftovi)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-authorized test
Enlicitide Decanoate (Lipfendra)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Low-density lipoprotein cholesterol
Ensartinib (Ensacove)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
ENSACOVE is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)as detected by an FDA-approved test [see Dosage and Administration ( 2.1 )] who have not previously received an ALK-inhibitor. ENSACOVE is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test who have not previously received an ALK-inhibitor. ( 1 , 2.1 )
Erlotinib (Erlotinib Hydrochloride / Tarceva)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Erlotinib tablets are a kinase inhibitor indicated for: • The treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test receiving first-line, maintenance, or second or greater line treatment after progression following at least one prior chemotherapy regimen. ( 1.1 ) • First-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer, in combination with gemcitabine.
Erythromycin Lactobionate (Erythrocin / Erythromycin / Erythrocin Lactobionate)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Erythromycin lactobionate for injection, USP is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. Intravenous therapy should be replaced by oral administration at the appropriate time.
Estrogens, Conjugated Synthetic B (Enjuvia)
Small chemical medicineApproved in the United States (FDA)Expanded record
Estrone (Folliculinum / Theelin / Natural Estrogenic Substance-Estrone / Estrogenic Substance)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Discomfort and aches associated with PMS*
Etanercept-Szzs (Erelzi)
Protein medicineApproved in the United States (FDA)Expanded record
Etanercept-Ykro (Eticovo)
Protein medicineApproved in the United States (FDA)Expanded record
Ethiodized Oil (Lipiodol)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Lipiodol is an oil-based radio-opaque contrast agent indicated for: hysterosalpingography in adults lymphography in adult and pediatric patients selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC) Lipiodol is an oil-based radiopaque contrast agent indicated for: hysterosalpingography in adults lymphography in adult and pediatric patients selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC)
Etidocaine (Duranest)
Small chemical medicineApproved in the United States (FDA)Expanded record
Etrasimod Arginine (Velsipity)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Moderately to severely active ulcerative colitis
Etretinate (Tegison)
Small chemical medicineApproved in the United States (FDA)Expanded record
Evinacumab-Dgnb (Evkeeza)
Protein medicineApproved in the United States (FDA)Expanded record
Ezogabine (Potiga)
Small chemical medicineApproved in the United States (FDA)Expanded record
Fenoldopam (Corlopam)
Small chemical medicineApproved in the United States (FDA)Expanded record
Fenoprofen (Nalfon / Fenopron Tm)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Fenoprofen calcium is indicated for: • Relief of mild to moderate pain in adults • Relief of the signs and symptoms of rheumatoid arthritis • Relief of the signs and symptoms of osteoarthritis Fenoprofen calcium is a nonsteroidal anti-inflammatory drug indicated for: • Relief of mild to moderate pain in adults. ( 1 ) • Relief of the signs and symptoms of rheumatoid arthritis. ( 1 ) • Relief of the signs and symptoms of osteoarthritis. ( 1 )
Ferric Citrate (Auryxia)
Small chemical medicineApproved in the United States (FDA)Expanded record
Ferric Derisomaltose (Monoferric)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Iron deficiency anemia
Ferric Oxyhydroxide (Velphoro)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Serum phosphorus levels
Ferrous (Ferrum Sulphuricum / Schuessler Tissue Salts Ferr Phos First Aid 4 / Ferrum Iodatum)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
SUGGESTED USE Adults: One (1) tablet daily, preferably after meals or as directed by the doctor. Children: As directed by the doctor.
Ferrous Citrate, Fe-59
Small chemical medicineApproved in the United States (FDA)Expanded record
Ferrous Sulfate (Ferrum Sulphuricum)
Small chemical medicineApproved in the United States (FDA)Expanded record
Ferumoxsil (Gastromark)
Small chemical medicineApproved in the United States (FDA)Expanded record
Fexinidazole
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in patients 6 years of age and older and weighing at least 20 kg. Fexinidazole Tablets is a nitroimidazole antimicrobial, indicated for the treatment of both first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in patients 6 years of age and older and weighing at least 20 kg.
Filgrastim-Sndz (Zarxio)
Protein medicineApproved in the United States (FDA)Expanded record
Finafloxacin (Xtoro)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus
Fingolimod Lauryl (Tascenso)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
TASCENSO ODT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. TASCENSO ODT is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. ( 1 )
Fish Oil Triglycerides (Omegaven)
Small chemical medicineApproved in the United States (FDA)Expanded record
Florquinitau F18 (Tauklarify)
Small chemical medicineApproved in the United States (FDA)Expanded record
Flortaucipir F-18 (Tauvid)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Use with positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary
Flumethasone Pivalate (Locorten)
Small chemical medicineApproved in the United States (FDA)Expanded record
Fluorodopa F-18
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Fluorodopa F 18 Injection is indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa F 18 PET is an adjunct to other diagnostic evaluations. Fluorodopa F 18 Injection is a radioactive diagnostic agent indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS).
Fluoroestradiol F-18 (Cerianna)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy
Fluoxymesterone (Halotestin / Ora-Testryl / Android-F)
Small chemical medicineApproved in the United States (FDA)Expanded record
Fluphenazine (Fluphenazine Hydrochloride / Prolixin / Permitil)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
INDICATIONS & USAGE Fluphenazine hydrochloride tablets are indicated in the management of manifestations of psychotic disorders. Fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation.
Fluphenazine Decanoate (Prolixin Decanoate / Fluphenazine)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics). Fluphenazine Decanoate Injection, USP has not been shown effective in the management of behavioral complications in patients with mental retardation.
Flurandrenolide (Cordran / Cordran Sp)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
The inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Flurpiridaz F-18 (Flyrcado)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Positron emission tomography (PET) myocardial perfusion imaging (MPI) under rest or stress
Flutemetamol F-18 (Vizamyl)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density
Fluvoxamine (Luvox / Fluvoxamine Maleate Extended-Release)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Obsessive compulsive disorder
Foscarnet (Foscavir)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
CMV retinitis
Fosdenopterin (Nulibry)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
The risk of mortality
Fosfomycin (Contepo / Monurol)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
CONTEPO is an epoxide antibacterial indicated for the treatment of patients 18 years of age and older with complicated urinary tract infections (cUTI) including acute pyelonephritis caused by susceptible isolates of Escherichia coli and Klebsiella pneumoniae . ( 1.1 ) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of CONTEPO and other antibacterial drugs, CONTEPO should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.
Fragrance 13576 (Anubis Barcelona / Anubis Barcelona Regul Oil / Anubis Barcelona Vital Line / Anubismed / Anubis Barcelona New Even / Anubis Barcelona Protective Line)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
AnubisMed 50+ Protection Fluid Indications and Usage
Futibatinib (Lytgobi)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
LYTGOBI is indicated for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements [see Dosage and Administration (2.1) ] . This indication is approved under accelerated approval based on overall response rate and duration of response [see Clinical Studies (14.1) ] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
Gadodiamide (Omniscan)
Small chemical medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Intravenous use

Dyclonine (Dyclopro / Dyclone / Sucrets Sore Throat Wild Cherry)

Dyphylline (Neothylline / Lufyllin / Dilor-400 / Dilor)

Echothiophate (Phospholine Iodide)

Eculizumab-Aagh (Epysqli)

Edaravone (Radicava / Radicava Ors)

Efbemalenograstim Alfa-Vuxw (Ryzneuta)

Efinaconazole (Jublia)

Elagolix Sodium, Estradiol, Norethindrone (Oriahnn (Copackaged))

Elexacaftor, Ivacaftor, Tezacaftor (Trikafta (Copackaged))

Eliglustat (Cerdelga)

Elosulfase alfa (Vimizim)

Elvitegravir (Vitekta)

Emapalumab-Lzsg (Gamifant)

Encorafenib (Braftovi)

Enlicitide Decanoate (Lipfendra)

Ensartinib (Ensacove)

Erlotinib (Erlotinib Hydrochloride / Tarceva)

Erythromycin Lactobionate (Erythrocin / Erythromycin / Erythrocin Lactobionate)

Estrogens, Conjugated Synthetic B (Enjuvia)

Estrone (Folliculinum / Theelin / Natural Estrogenic Substance-Estrone / Estrogenic Substance)

Etanercept-Szzs (Erelzi)

Etanercept-Ykro (Eticovo)

Ethiodized Oil (Lipiodol)

Etidocaine (Duranest)

Etrasimod Arginine (Velsipity)

Etretinate (Tegison)

Evinacumab-Dgnb (Evkeeza)

Ezogabine (Potiga)

Fenoldopam (Corlopam)

Fenoprofen (Nalfon / Fenopron Tm)

Ferric Citrate (Auryxia)

Ferric Derisomaltose (Monoferric)

Ferric Oxyhydroxide (Velphoro)

Ferrous (Ferrum Sulphuricum / Schuessler Tissue Salts Ferr Phos First Aid 4 / Ferrum Iodatum)

Ferrous Citrate, Fe-59

Ferrous Sulfate (Ferrum Sulphuricum)

Ferumoxsil (Gastromark)

Fexinidazole

Filgrastim-Sndz (Zarxio)

Finafloxacin (Xtoro)

Fingolimod Lauryl (Tascenso)

Fish Oil Triglycerides (Omegaven)

Florquinitau F18 (Tauklarify)

Flortaucipir F-18 (Tauvid)

Flumethasone Pivalate (Locorten)

Fluorodopa F-18

Fluoroestradiol F-18 (Cerianna)

Fluoxymesterone (Halotestin / Ora-Testryl / Android-F)

Fluphenazine (Fluphenazine Hydrochloride / Prolixin / Permitil)

Fluphenazine Decanoate (Prolixin Decanoate / Fluphenazine)

Flurandrenolide (Cordran / Cordran Sp)

Flurpiridaz F-18 (Flyrcado)

Flutemetamol F-18 (Vizamyl)

Fluvoxamine (Luvox / Fluvoxamine Maleate Extended-Release)

Foscarnet (Foscavir)

Fosdenopterin (Nulibry)

Fosfomycin (Contepo / Monurol)

Fragrance 13576 (Anubis Barcelona / Anubis Barcelona Regul Oil / Anubis Barcelona Vital Line / Anubismed / Anubis Barcelona New Even / Anubis Barcelona Protective Line)

Futibatinib (Lytgobi)

Gadodiamide (Omniscan)